Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lazzarin

Showing results (331-340 of 384) with videos related to

Pageof 39
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2000
Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapyS Fleury, G P Rizzardi, A Chapuis, et al.
International Journal of Immunopathology and Pharmacology|February 20, 2003
Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART studyN. Gianotti, M. Setti, P. E. Manconi, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1997
Heterogeneity in exposed uninfected individualsL Lopalco, C Pastori, C Barassi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 22, 2010
Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruptionF Canducci, B Barda, E Ceresola, et al.
AIDS (London, England)|August 1, 1996
Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patientsP Cinque, L Vago, H Dahl, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2020
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)S Nozza, R Ferrarese, A Poli, et al.
Clinical and Experimental Immunology|November 14, 1997
Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infectionD Roccatello, G Morsica, G Picciotto, et al.
The Journal of Infectious Diseases|August 19, 2000
Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infectionD Smith, M M Berrey, M Robertson, et al.
Peptides|January 1, 1994
Beta-endorphin content in HIV-infected HuT78 cell line and in peripheral lymphocytes from HIV-positive subjectsW Barcellini, P Sacerdote, M O Borghi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 26, 2016
Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis CC Sagnelli, M Merli, C Uberti-Foppa, et al.
Pageof 39

Showing results (331-340 of 384) with videos related to

Sort By:
Pageof 39
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2000
Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapyS Fleury, G P Rizzardi, A Chapuis, et al.
International Journal of Immunopathology and Pharmacology|February 20, 2003
Reverse transcriptase mutations in HIV-1 infected patients treated with two nucleoside analogues: the SMART studyN. Gianotti, M. Setti, P. E. Manconi, et al.
Journal of Biological Regulators and Homeostatic Agents|January 1, 1997
Heterogeneity in exposed uninfected individualsL Lopalco, C Pastori, C Barassi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 22, 2010
Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruptionF Canducci, B Barda, E Ceresola, et al.
AIDS (London, England)|August 1, 1996
Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patientsP Cinque, L Vago, H Dahl, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2020
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)S Nozza, R Ferrarese, A Poli, et al.
Clinical and Experimental Immunology|November 14, 1997
Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infectionD Roccatello, G Morsica, G Picciotto, et al.
The Journal of Infectious Diseases|August 19, 2000
Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infectionD Smith, M M Berrey, M Robertson, et al.
Peptides|January 1, 1994
Beta-endorphin content in HIV-infected HuT78 cell line and in peripheral lymphocytes from HIV-positive subjectsW Barcellini, P Sacerdote, M O Borghi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 26, 2016
Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis CC Sagnelli, M Merli, C Uberti-Foppa, et al.
Pageof 39